C-8813

C-8813

Gene therapy
Clinical data
Physiological data
Legal status
Legal status	In general: legal
Pharmacokinetic data
Identifiers
IUPAC name trans-4-(p-Bromophenyl)-4-(dimethylamino)-1-(2-(thiophen-2-yl)ethyl)cyclohexanol
PubChem Template:Abbreviation	11058633
Chemical and physical data
Formula	C20H26BrNOS
Molar mass	408.394 g/mol
3D model (JSmol)	Interactive image
SMILES c1cc(Br)ccc1C3(N(C)C)CCC(O)(CC3)CCc2sccc2

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

C-8813 is a potent μ-opioid agonist with a distinctive chemical structure which is not closely related to other established families of opioid drugs. It was found to be around 591x more potent than morphine in animal studies.

C-8813 has never been used in humans, but would be expected to produce effects similar to those of other potent opioid agonists, including strong analgesia, sedation, euphoria, constipation, itching and respiratory depression which could be harmful or fatal.

See Also

• 4-(p-Bromophenyl)-4-(dimethylamino)-1-phenethylcyclohexanol